Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 20 2025
0mins
Source: Newsfilter
Research Agreement Announcement: Avicanna Inc. has entered into a Sponsored Research Agreement to fund a study on the effectiveness of oral cannabis extracts for osteoarthritic pain, led by Dr. Hance Clarke, with the trial expected to start in Fall 2025.
Company Overview: Avicanna is a biopharmaceutical company focused on developing and commercializing cannabinoid-based products, with a diverse range of proprietary products and a medical cannabis care platform aimed at enhancing patient support and education.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
